Every few weeks, another American family climbs into a car at the San Diego border and drives south toward a clinic they found on the internet.
A son or daughter has been through rehab three or four times.
Someone in a Facebook group swore that a single dose of a plant-based drug called ibogaine erased decades of addiction overnight.
So they pay $8,000 to $15,000 in cash and hand their child to strangers in a foreign country.
Ibogaine is a psychoactive compound derived from the root bark of a West African shrub.
It is illegal in the United States, where it is classified as a Schedule I drug.
But south of the border, in Tijuana, Cancún, and beach towns along the Baja coast, a booming gray-market industry has sprung up promising what American medicine will not: a reset for the addicted brain.
The problem is that ibogaine can kill you.
The drug disrupts the heart's electrical rhythm, a condition called QT prolongation, and has been linked to sudden cardiac death.
A 2018 review in a peer-reviewed journal found that at least nineteen deaths had been associated with ibogaine, and researchers say the real number is almost certainly higher because deaths abroad are rarely counted at home.
Clinics in Mexico operate with little oversight.
Some employ real doctors and run EKGs before dosing.
Others are little more than rented villas with a mattress, a bucket, and a caretaker who has never managed a cardiac emergency.
When a patient's heart stops, there is often no defibrillator and no ambulance willing to make the trip.
The body comes home in a coffin, and the family is left with a story no one wants to hear.
What makes this a distinctly American tragedy is how the demand got created.
The United States has roughly 50 million people struggling with substance use, a treatment system with waiting lists and brutal relapse rates, and an insurance industry that covers thirty days of talk therapy but not a trip to a clinic that might actually interrupt the cycle.
Into that gap steps the internet, where testimonials travel faster than warnings and grief-stricken parents make decisions at 2 a.m. with a credit card in hand.
There is real science here, which is what makes the whole thing so maddening.
Ibogaine has shown genuine promise in small studies and decades of anecdotal reports for interrupting opioid and cocaine dependence.
Researchers at major American universities have tried for years to study it properly.
The Schedule I designation makes that nearly impossible, so the evidence stays thin, the clinics stay unregulated, and desperate people keep crossing the border because the alternative at home is a three-month wait for a bed.
That is a vacuum, and markets fill vacuums.
When a nation refuses to study a substance, it does not make the substance disappear.
It just exports the risk to people who cannot afford to wait for permission.
The families driving south are not reckless.
They are doing math the rest of us refuse to do.
A country that won't fund the research, won't approve the treatment, and won't fix the rehab system has no standing to lecture them at the border.
Final Thoughts
Either way, the answer isn't to look away while Americans die in villas we refuse to regulate.